A previous study reported that YTHDF1 could recognize m6A-marked transcripts encoding lysosomal proteases and result in degradation of neoantigens in dendritic cells, thereby suppressing cross-presentation of tumor neoantigens and cross-priming of CD8+ T cells 28. This evidence concerns the gene YTHDF1 and neoplasm.